AMGN
Amgen Inc
379.80$
+0.9%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 50.3% | 53.8% | 59.3% | 61.9% | 56.6% | 30.9% | 33.6% | 31.7% | 34.1% | 31.2% | 31.6% | 32.1% | |
| 5.4% | 5.8% | 4.2% | 4.8% | 10.5% | 10.1% | 10.0% | 13.1% | 11.7% | 11.3% | 13.0% | 10.1% | |
| 39.2% | 43.8% | 49.1% | 52.1% | 44.1% | 14.9% | 16.9% | 13.1% | 14.3% | 11.3% | 13.0% | 10.1% | |
| 3.7% | 4.2% | 4.1% | 4.0% | 5.4% | 6.8% | 7.2% | 9.5% | 9.8% | 8.2% | 8.2% | 10.6% | |
| 3.8% | 3.4% | 3.5% | 3.5% | 4.4% | 6.0% | 6.2% | 6.7% | 7.6% | 9.8% | 7.6% | 6.9% | |
| 7.6% | 6.9% | 6.4% | 6.2% | 7.5% | 8.3% | 7.8% | 8.5% | 8.3% | – | – | – | |
| 21.4% | 20.7% | 19.0% | 18.5% | 22.1% | 24.6% | 23.3% | 24.3% | 23.8% | 19.2% | 20.3% | 20.6% | |
| 18.4% | 16.3% | 13.2% | 10.8% | 11.2% | 32.5% | 26.4% | 24.8% | 24.7% | 33.6% | 30.2% | 24.6% | |
| 62.6% | 60.6% | 61.5% | 68.4% | 81.2% | 83.8% | 85.1% | 89.0% | 94.4% | 93.6% | 93.6% | 90.4% | |
| 10.2% | 12.1% | 14.4% | 11.3% | 20.3% | 21.5% | 18.5% | 19.9% | 24.1% | 18.9% | 25.2% | 28.1% | |
| 0.7% | 3.1% | 5.7% | 1.4% | 6.7% | 4.9% | 0.1% | 0.1% | 2.4% | 1.5% | 3.9% | 5.1% | |
| 1.4% | 1.3% | 1.2% | 1.7% | 1.8% | 2.3% | 2.3% | 2.2% | 2.4% | 1.6% | 2.1% | 2.6% | |
| 43.8% | 40.9% | 38.9% | 42.8% | 44.4% | 45.1% | 52.3% | 54.3% | 57.4% | 65.0% | 61.6% | 55.2% | |
| 37.4% | 39.2% | 38.5% | 31.6% | 18.8% | 16.2% | 14.9% | 11.0% | 5.6% | 6.4% | 6.4% | 9.6% | |
| -6.7% | -2.9% | -0.6% | -6.3% | -27.1% | -35.7% | -34.0% | -40.2% | -44.0% | -27.3% | -30.0% | -27.7% | |
| 1.1% | 1.1% | 1.0% | 0.9% | 1.0% | 1.0% | 0.9% | 0.9% | 0.8% | 0.6% | 0.6% | 0.6% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.